Provided by Tiger Trade Technology Pte. Ltd.

Eton Pharmaceuticals, Inc.

63.47
+3.565.94%
Post-market: 63.940.4700+0.74%19:44 EDT
Volume:640.79K
Turnover:40.08M
Market Cap:1.81B
PE:162.74
High:64.00
Open:59.76
Low:59.76
Close:59.91
52wk High:64.00
52wk Low:14.27
Shares:28.58M
Float Shares:26.68M
Volume Ratio:0.56
T/O Rate:2.40%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.3900
EPS(LYR):-0.1710
ROE:35.97%
ROA:11.86%
PB:38.94
PE(LYR):-371.19

Loading ...

Eton Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Mar 02

Eton Pharmaceuticals Inc - Deal Will Be Financed With Company's Cash on Hand

THOMSON REUTERS
·
Mar 02

Eton Pharmaceuticals Inc - Licenses U.S. Rights to Hemangeol

THOMSON REUTERS
·
Mar 02

Eton Pharmaceuticals Expands Rare Disease Portfolio Through Acquisition of U.S. Commercialization Rights to Hemangeol® (Propranolol Hydrochloride) Oral Solution

THOMSON REUTERS
·
Mar 02

Eton Pharmaceuticals : Will Also Purchase Approximately $1.5 Mln of Inventory at Closing and an Estimated $0.7 Mln of Inventory in May 2026

THOMSON REUTERS
·
Mar 02

Eton Pharmaceuticals Inc - to Pay $14 Mln Upfront and 8% Royalty - SEC Filing

THOMSON REUTERS
·
Mar 02

Eton Pharmaceuticals : Entered Into Licensing Agreement and Acquired U.S. Rights to Hemangeol Oral Solution From Pierre Fabre Medicament Sas

THOMSON REUTERS
·
Mar 02

Eton Pharmaceuticals Inc: Transaction Was Financed by Company's Cash on Hand

THOMSON REUTERS
·
Mar 02

Eton Pharmaceuticals Inc - Deal Expected Accretive to 2026 Earnings - SEC Filing

THOMSON REUTERS
·
Mar 02

Eton Pharmaceuticals acquires U.S. commercialization rights to Hemangeol oral solution from Pierre Fabre

Reuters
·
Mar 02

Eton Pharmaceuticals price target raised to $37 from $35 at H.C. Wainwright

TIPRANKS
·
Mar 02

Analysts Offer Insights on Healthcare Companies: Eton Pharmaceuticals (ETON) and Atai Beckley N.V. (ATAI)

TIPRANKS
·
Feb 27

Eton Pharmaceuticals Rises After an FDA Approval But Pares Gains

Dow Jones
·
Feb 26

Eton Pharmaceuticals announces FDA approval for Desmoda Oral Solution

TIPRANKS
·
Feb 26

US FDA approves Eton Pharma's hormonal disorder drug

Reuters
·
Feb 26

FDA approves Eton Pharmaceuticals’ DESMODA desmopressin oral solution

Reuters
·
Feb 26

Eton Pharmaceuticals Announces U.S. FDA Approval for Desmoda™ (Desmopressin Acetate) Oral Solution

THOMSON REUTERS
·
Feb 26

Eton Pharmaceuticals Inc - Desmoda Commercial Launch Expected on March 9TH

THOMSON REUTERS
·
Feb 26

Eton Pharmaceuticals Inc - Desmoda Expected Peak Sales of $30 Mln-$50 Mln Annually

THOMSON REUTERS
·
Feb 26

Eton Pharmaceuticals trading halted, news pending

TIPRANKS
·
Feb 26